Latest Breaking News On - இயக்குனர் மருந்து - Page 4 : comparemela.com

Subscribe Growing in APAC: Swedish probiotic firm Probi expands China market via new deal with Sinopharm Foreign Trade By Tingmin Koe Swedish probiotic firm Probi is expanding its presence in APAC via a new deal with China National Pharmaceutical Foreign Trade Corporation (Sinopharm Foreign Trade). Established in 1981, Sinopharm Foreign Trade is a wholly-owned subsidiary of China National Pharmaceutical Group Corporation, also widely known as Sinopharm – one of the China companies that have successfully developed COVID-19 vaccines. Under the partnership, Sinopharm Foreign Trade will be launching probiotic products for immune health, bone health, and iron absorption with probiotic strains backed by Probi’s research and clinical data.

Jian geSouth koreaProbi defendumMorishita jintanProbi ferrosorbChina national pharmaceutical group corporationChemical division of sinopharm foreignSinopharm foreign tradeProbi osteoDirector pharmaceuticalChemical divisionSinopharm xingshaXingsha pharmaceuticalProbiotics amp prebioticsஜியான் கேதெற்கு கொரியா